Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > pmps > Summer 2008

PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

Summer 2008

At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.

Text

PDF

Manufacturing

X-Ray systems are becoming increasingly valued by the pharmaceutical industry as an indispensable means of non-destructive testing; Martin Allen of Shaw Inspection Systems takes a closer look

The automated CheckWeighing system for dry powder inhalers supports the quality assurance process, outlines James Aitken of Aitken Scientific

Elisabethann Wright of Hogan & Hartson Brussels consider the European Commision’s attempts to strengthen the legal framework for regulating medical devices in Europe

Tom Roche at FM Global assesses how a single incident in one country can have a disastrous impact on the entire global economy

Drug Delivery

Frances L DeGrazio at West Pharmaceutical Services, Inc, outlines the procedures involved and the importance of thorough testing in the leachables and extractables field

Stephen Grant at ANSYS discusses how computational fluid dynamics (CFD) enable a fast and cost-effective evaluation of new drug delivery systems and formulations

Douglas Custato at Helvoet Pharma outlines the options pharma companies will be presented with when choosing the ideal elastomeric closure

Andy Wallace at Comark Ltd encourages investment in wireless monitoring systems – a key tool for those looking to expand into emerging markets

Formulations, Ingredients and Excipients

Many active pharmaceutical ingredients are unstable and subject to degradation. The role of excipients is therefore being viewed as progressively more important. Nigel A Langley and Karen H Chen at Croda Inc (USA) explain how.

Dr Robert Hardy of Aesica explains to PMPS that exceptional service and a well-balanced business model is key in providing contract services to the outsourcing industry

IT and Logistics

Guido Moosmann of Schreiner MediPharm explores the latest innovative technologies for clinical trial supply management

PACKING, PACKAGING & ANTI-COUNTERFEITING

John Haworth at Ditone Labels looks at how the pharma packaging industry has responded to the needs of the blind community

Nicole Golomb at 3S Simons Security Systems GmbH takes us through the various options available to avoid the counterfeit risk

Low and microdose powder filling in the pharmaceutical industry has traditionally been a challenging process. However, new developments are on the way, as Robin Davies of Isopak Ltd explains

COOL CHAIN

Robert Kayum at Kuehne + Nagel explores today’s climate for temperature-sensitive logistics, and the developments in solutions that can transform the role they play in the pharma industry

Published quarterly in
February, May,
August, and November

News and Press Releases

New assurance first for plastic pollution reduction

Businesses in the pharmaceutical sector can now take significant verifiable steps to manage plastic waste and its impact on the environment, thanks to the launch of the world’s first best-practice standard for Responsible Plastic Management (RPM).
More info >>

All releases >>

White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>

All white papers >>

Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

All events >>